NCT06587178

Brief Summary

Growing evidence has shown that exclusive enteral nutrition (EEN) plays an important role in the preoperative optimization for patients with Crohn's disease (CD). However, the efficacy and safety of different types of enteral feeds including semi-elemental and polymeric enteral nutrition on CD have not been investigated. The aim of this study was to compare the role of semi-elemental and polymeric enteral nutrition on CD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
304

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 3, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.2 years

First QC Date

September 3, 2024

Last Update Submit

September 5, 2024

Conditions

Keywords

Crohn's diseaseExclusive enteral nutritionsurgery

Outcome Measures

Primary Outcomes (1)

  • The change of CRP/ALB level

    The ratio of C-reactive protein to albumin level changed after exclusive enteral nutrition.

    6 weeks

Secondary Outcomes (4)

  • BMI

    6 weeks

  • CDAI

    6 weeks

  • postoperative complications

    6 weeks

  • adverse reaction

    6 weeks

Study Arms (2)

SED patient

EXPERIMENTAL

SED patients who received semi-elemental exclusive enteral nutrition.

Dietary Supplement: peptison liquid

PD patient

PLACEBO COMPARATOR

PD patients who received polymeric exclusive enteral nutrition.

Dietary Supplement: Enteral nutritional suspension

Interventions

peptison liquidDIETARY_SUPPLEMENT

CD patients requiring bowel resection and preoperative EEN were randomized to receive peptison liquid for 6 weeks.

Also known as: Nutricia, Amsterdam, Netherlands
SED patient

CD patients requiring bowel resection and preoperative EEN were randomized to receive enteral nutritional suspension for 6 weeks.

Also known as: Nutricia, Amsterdam, Netherlands
PD patient

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elective bowel resection for Crohn's disease;
  • preoperative diagnosis of Crohn's disease;
  • age between 18 to 65 years old;
  • malnutrition;
  • the Crohn's disease activity index over 150;
  • nasal feeding.

You may not qualify if:

  • emergency surgery;
  • preoperative exclusive enteral nutrition before three months;
  • can not tolerate enteral nutrition;
  • less than 6 weeks of exclusive enteral nutrition;
  • preoperative corticosteroids within 3 months;
  • history of gastrointestinal surgery;
  • isolated colon disease;
  • metabolic disease (diabetes, hyperthyroidism).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wei Zhou

Hangzhou, Zhejiang, 310016, China

Location

MeSH Terms

Conditions

Crohn DiseaseNutrition Disorders

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesNutritional and Metabolic Diseases

Study Officials

  • Xiujun Cai

    Sir Run Run Shaw Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

September 3, 2024

First Posted

September 19, 2024

Study Start

October 1, 2024

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

The data can be available from the email (gxlmed@zju.edu.cn)

Locations